Burden of Disease

Key Data:

Prospective assessments can be a reliable way of capturing the full burden of disease from an unselected population shortly after diagnosis of AF.

GARFIELD-AF has reported 2-year incidence rates of adverse outcomes in patients newly diagnosed with AF.

Rates for major outcomes were highest during the first 4 months (figure).

(Bassand et al 2016)

Four-monthly rate ratios for all-cause mortality (A), stroke/systemic embolism (B), and major bleeding (C). What is shown is the ratio between the observed number of events in the period and the expected number of events obtained by applying the overall rate to the period. Only the first occurrence of each event was taken into account.

(Bassand et al 2016)

Key Publications

Related Publications

Click to view publications related to Burden of Disease... [read more]

16 Jun 21

Global status

Read more
Total patients 57,262
Recruitment Recruitment closed
Study end: 2018

Members Login

Coming soon… If you would like to be notified of when this is available click here and add your details to receive updates

Newsletter Signup

    Please see our Privacy Policy and Cookie Policy

    Contact Us

      To find out more about GARFIELD-AF, please contact the Thrombosis Research Institute

      E: garfield@tri-london.ac.uk
      T: 0203 198 9947